Christine A. Poon's Insider Trades & SAST Disclosures
Christine A. Poon's most recent trade in Neurocrine Biosciences, Inc. was a trade of 3,318 Restricted Stock Unit done . Disclosure was reported to the exchange on May 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christine A. Poon.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neurocrine Biosciences, Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 3,318 | 3,318 | - | - | Restricted Stock Unit | |
| Neurocrine Biosciences, Inc. | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 1,435 | 0 | - | - | Restricted Stock Unit | |
| Neurocrine Biosciences, Inc. | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 1,435 | 1,435 (0%) | 0% | 0 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 1,675 | 1,675 | - | - | 2025 Restricted Stock Units | |
| Prudential Financial Inc. | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 1,321 | 12,904 (0%) | 0% | 0 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Sale or transfer of securities back to the company at price $ 107.40 per share. | 13 May 2025 | 1,321 | 11,583 (0%) | 0% | 107.4 | 141,875 | Common Stock |
| Prudential Financial Inc. | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 1,321 | 0 | - | - | 2024 Restricted Stock Units | |
| Sherwin-Williams Co. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 347.50 per share. | 04 Apr 2025 | 4 | 2,573 (0%) | 0% | 347.5 | 1,390 | Common Stock |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 162 | 12,819 | - | - | Notional Shares - Mandatory | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 49 | 3,934 | - | - | Notional Shares - Optional | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 16 | 1,321 | - | - | 2024 Restricted Stock Units | |
| Sherwin-Williams Co. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 517 | 12,386 (0%) | 0% | 0 | Common Stock | |
| Sherwin-Williams Co. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 337.56 per share. | 03 Jan 2025 | 25 | 2,563 (0%) | 0% | 337.6 | 8,439 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,958 | 1,958 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 166 | 2,352 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | 02 Jan 2025 | 14 | 2,186 (0%) | 0% | 0 | Common Stock | ||
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 134 | 12,656 | - | - | Notional Shares - Mandatory | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 41 | 3,884 | - | - | Notional Shares - Optional | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 13 | 1,304 | - | - | 2024 Restricted Stock Units | |
| Sherwin-Williams Co. | Christine A. Poon | Director | 04 Oct 2024 | 22 | 2,533 (0%) | 0% | 383.5 | 8,436 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 138 | 12,521 | - | - | Notional Shares - Mandatory | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 42 | 3,843 | - | - | Notional Shares - Optional | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 14 | 1,290 | - | - | 2024 Restricted Stock Units | |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 413.33 per share. | 15 Aug 2024 | 10,838 | 13,010 (0%) | 0% | 413.3 | 4,479,671 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 10,838 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 1159.56 per share. | 15 Aug 2024 | 5,352 | 2,506 (0%) | 0% | 1159.6 | 6,205,965 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 1156.30 per share. | 15 Aug 2024 | 2,368 | 9,630 (0%) | 0% | 1156.3 | 2,738,118 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 1157.33 per share. | 15 Aug 2024 | 1,560 | 8,070 (0%) | 0% | 1157.3 | 1,805,435 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 1155.72 per share. | 15 Aug 2024 | 1,012 | 11,998 (0%) | 0% | 1155.7 | 1,169,589 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 1160.45 per share. | 15 Aug 2024 | 234 | 2,272 (0%) | 0% | 1160.4 | 271,545 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 1158.02 per share. | 15 Aug 2024 | 212 | 7,858 (0%) | 0% | 1158.0 | 245,500 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 1161.32 per share. | 15 Aug 2024 | 100 | 2,172 (0%) | 0% | 1161.3 | 116,132 | Common Stock |
| Sherwin-Williams Co. | Christine A. Poon | Director | 05 Jul 2024 | 28 | 2,505 (0%) | 0% | 301.3 | 8,437 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 139 | 12,382 | - | - | Notional Shares - Mandatory | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 42 | 3,800 | - | - | Notional Shares - Optional | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 14 | 1,276 | - | - | 2024 Restricted Stock Units | |
| Neurocrine Biosciences, Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 2,982 | 2,982 | - | - | Non-Qualified Stock Option | |
| Neurocrine Biosciences, Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 1,435 | 1,435 | - | - | Restricted Stock Unit | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 1,261 | 1,261 | - | - | 2024 Restricted Stock Units | |
| Prudential Financial Inc. | Christine A. Poon | Director | Sale or transfer of securities back to the company at price $ 117.95 per share. | 09 May 2024 | 1,935 | 11,583 (0%) | 0% | 117.9 | 228,233 | Common Stock |
| Prudential Financial Inc. | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 1,935 | 0 | - | - | 2023 Restricted Stock Units | |
| Prudential Financial Inc. | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 1,935 | 13,518 (0%) | 0% | 0 | Common Stock | |
| Sherwin-Williams Co. | Christine A. Poon | Director | 05 Apr 2024 | 25 | 2,471 (0%) | 0% | 337.5 | 8,438 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 140 | 12,243 | - | - | Notional Shares - Mandatory | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 43 | 3,757 | - | - | Notional Shares - Optional | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 22 | 1,935 | - | - | 2023 Restricted Stock Units | |
| Sherwin-Williams Co. | A. Christine Poon | Director | 13 Feb 2024 | 594 | 11,869 (0%) | 0% | 0 | Common Stock | ||
| Sherwin-Williams Co. | A. Christine Poon | Director | 05 Jan 2024 | 28 | 2,440 (0%) | 0% | 301.3 | 8,437 | Common Stock | |
| Regeneron Pharmaceuticals,... | Poon A. Christine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 1,607 | 1,607 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 135 | 2,172 (0%) | 0% | 0 | Common Stock | |
| Prudential Financial Inc. | A. Christine Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 142 | 12,102 | - | - | Notional Shares - Mandatory | |
| Prudential Financial Inc. | Christine Poon A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 43 | 3,714 | - | - | Notional Shares - Optional | |
| Prudential Financial Inc. | A. Christine Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 22 | 1,913 | - | - | 2023 Restricted Stock Units | |
| Sherwin-Williams Co. | Christine A. Poon | Director | 06 Oct 2023 | 32 | 2,407 (0%) | 0% | 253.9 | 8,126 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2023 | 148 | 11,960 | - | - | Notional Shares - Mandatory | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2023 | 45 | 3,671 | - | - | Notional Shares - Optional | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2023 | 23 | 1,890 | - | - | 2023 Restricted Stock Units | |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2023 | 12,280 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 273.67 per share. | 23 Aug 2023 | 12,280 | 14,317 (0%) | 0% | 273.7 | 3,360,668 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 840.65 per share. | 23 Aug 2023 | 6,450 | 2,537 (0%) | 0% | 840.7 | 5,422,193 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 839.45 per share. | 23 Aug 2023 | 3,032 | 8,987 (0%) | 0% | 839.4 | 2,545,212 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 838.60 per share. | 23 Aug 2023 | 1,998 | 12,019 (0%) | 0% | 838.6 | 1,675,523 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 841.05 per share. | 23 Aug 2023 | 500 | 2,037 (0%) | 0% | 841.1 | 420,525 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 837.92 per share. | 23 Aug 2023 | 300 | 14,017 (0%) | 0% | 837.9 | 251,376 | Common Stock |
| Neurocrine Biosciences, Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2023 | 16,375 | 16,375 | - | - | Non-Qualified Stock Option | |
| Sherwin-Williams Co. | Christine A. Poon | Director | 07 Jul 2023 | 31 | 2,370 (0%) | 0% | 262.1 | 8,126 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 167 | 11,811 | - | - | Notional Shares - Mandatory | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 51 | 3,625 | - | - | Notional Shares - Optional | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 26 | 1,867 | - | - | 2023 Restricted Stock Units | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 1,840 | 1,840 | - | - | 2023 Restricted Stock Units | |
| Prudential Financial Inc. | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 1,517 | 13,100 (0%) | 0% | 0 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 1,517 | 0 | - | - | 2022 Restricted Stock Units | |
| Prudential Financial Inc. | Christine A. Poon | Director | Sale or transfer of securities back to the company at price $ 81.50 per share. | 09 May 2023 | 1,517 | 11,583 (0%) | 0% | 81.5 | 123,636 | Common Stock |
| Sherwin-Williams Co. | Christine A. Poon | Director | 10 Apr 2023 | 36 | 2,332 (0%) | 0% | 225.7 | 8,124 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 174 | 11,643 | - | - | Notional Shares - Mandatory | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 53 | 3,573 | - | - | Notional Shares - Optional | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 22 | 1,517 | - | - | 2022 Restricted Stock Units | |
| Sherwin-Williams Co. | Christine A. Poon | Director | 14 Feb 2023 | 711 | 11,275 (0%) | 0% | 0 | Common Stock | ||
| Sherwin-Williams Co. | Christine A. Poon | Director | 06 Jan 2023 | 34 | 2,289 (0%) | 0% | 238.9 | 8,124 | Common Stock | |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,929 | 1,929 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 165 | 2,037 (0%) | 0% | 0 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 136 | 11,469 | - | - | Notional Shares - Mandatory | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 41 | 3,520 | - | - | Notional Shares - Optional | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 17 | 1,494 | - | - | 2022 Restricted Stock Units | |
| Sherwin-Williams Co. | Christine A. Poon | Director | 07 Oct 2022 | 38 | 2,249 (0%) | 0% | 213.8 | 8,126 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 145 | 11,332 | - | - | Notional Shares - Mandatory | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 44 | 3,478 | - | - | Notional Shares - Optional | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 18 | 1,476 | - | - | 2022 Restricted Stock Units | |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 177.82 per share. | 09 Aug 2022 | 15,000 | 16,872 (0%) | 0% | 177.8 | 2,667,300 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 15,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 621.27 per share. | 09 Aug 2022 | 8,186 | 1,872 (0%) | 0% | 621.3 | 5,085,716 | Common Stock |
| Regeneron Pharmaceuticals,... | Christine A. Poon | Director | Sale of securities on an exchange or to another person at price $ 620.47 per share. | 09 Aug 2022 | 6,814 | 10,058 (0%) | 0% | 620.5 | 4,227,883 | Common Stock |
| Sherwin-Williams Co. | Christine A. Poon | Director | 08 Jul 2022 | 34 | 2,205 (0%) | 0% | 239.0 | 8,125 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 145 | 11,187 | - | - | Notional Shares - Mandatory | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 44 | 3,433 | - | - | Notional Shares - Optional | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 18 | 1,457 | - | - | 2022 Restricted Stock Units | |
| Prudential Financial Inc. | Christine A. Poon | Director | Sale or transfer of securities back to the company at price $ 104.25 per share. | 10 May 2022 | 1,494 | 11,583 (0%) | 0% | 104.3 | 155,750 | Common Stock |
| Prudential Financial Inc. | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2022 | 1,494 | 13,077 (0%) | 0% | 0 | Common Stock | |
| Prudential Financial Inc. | Christine A. Poon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2022 | 1,494 | 0 | - | - | 2021 Restricted Stock Units | |
| Prudential Financial Inc. | Christine A. Poon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 1,438 | 1,438 | - | - | 2022 Restricted Stock Units | |
| Sherwin-Williams Co. | Christine A. Poon | Director | 08 Apr 2022 | 30 | 2,166 (0%) | 0% | 270.9 | 8,126 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges